21
Aug

Baxter’s latest hemophilia candidate met its main goals in a late-stage study, clearing the way for an FDA application as the biopharma giant works to expand its cadre of bleeding drugs.

…read more

Source: Baxter’s next hemophilia drug clocks a Phase III success

    

0 No comments